Alere ( ALR) develops and markets consumer and professional point-of-care diagnostic devices. The firm's devices target cardiology, oncology, drug abuse and women's health-care sectors. Church says "we think this is where the future of health care is migrating to -- the use of a monitoring device from home. It's keeping people out of hospitals or the doctor's office" through the use of wireless communications on medical monitoring devices. Just as everything else is going mobile, this is mobile health care." Alere's shares have lost 37% this year, but have a three-year average annual return of 12%, resulting in a market value of $2 billion.